Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic DiseasesShimon Slavin, Reuven Or, Arnon Nagler et al.|Blood|1998Cited by 1.9k
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic DiseasesShimon Slavin, Reuven Or, Arnon Nagler et al.|Blood|1998Cited by 1.8k
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase DeficiencyAlessandro Aiuti, Maria‐Grazia Roncarolo, Federica Cattaneo et al.|New England Journal of Medicine|2009Cited by 1k
Neuroprotection and Immunomodulation With Mesenchymal Stem Cells in Chronic Experimental Autoimmune EncephalomyelitisIbrahim Kassis, Dimitrios Karussis, Nikolaos Grigoriadis et al.|Archives of Neurology|2008Cited by 338
Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phaseReuven Or, Shimon Slavin, Michael Y. Shapira et al.|Blood|2002Cited by 213